These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38804605)

  • 1. Racial-ethnic differences in liver transplant waitlist outcomes in patients with hepatocellular carcinoma before and after recent changes to allocation policy.
    Mazur RD; Cron DC; Goldberg DS; Yeh H; Dageforde LA
    Clin Transplant; 2024 Jun; 38(6):e15365. PubMed ID: 38804605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Disparities in Candidates for Hepatocellular Carcinoma Liver Transplant After 6-Month Wait Policy Change.
    Saberi B; Gurakar A; Tamim H; Schneider CV; Sims OT; Bonder A; Fricker Z; Alqahtani SA
    JAMA Netw Open; 2023 Nov; 6(11):e2341096. PubMed ID: 37917059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and ethnic disparities in lung transplant listing and waitlist outcomes.
    Mooney JJ; Hedlin H; Mohabir P; Bhattacharya J; Dhillon GS
    J Heart Lung Transplant; 2018 Mar; 37(3):394-400. PubMed ID: 29129372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and ethnic disparities in access to liver transplantation.
    Mathur AK; Schaubel DE; Gong Q; Guidinger MK; Merion RM
    Liver Transpl; 2010 Sep; 16(9):1033-40. PubMed ID: 20818740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Waitlist Outcomes for Exception and Non-exception Liver Transplant Candidates in the United States Following Implementation of the Median MELD at Transplant (MMaT)/250-mile Policy.
    Ishaque T; Beckett J; Gentry S; Garonzik-Wang J; Karhadkar S; Lonze BE; Halazun KJ; Segev D; Massie AB
    Transplantation; 2024 Aug; 108(8):e170-e180. PubMed ID: 38548691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation and waitlist mortality for HCC and non-HCC candidates following the 2015 HCC exception policy change.
    Ishaque T; Massie AB; Bowring MG; Haugen CE; Ruck JM; Halpern SE; Waldram MM; Henderson ML; Garonzik Wang JM; Cameron AM; Philosophe B; Ottmann S; Rositch AF; Segev DL
    Am J Transplant; 2019 Feb; 19(2):564-572. PubMed ID: 30312530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of surging transplantation of alcohol-associated liver disease on transplantation for HCC and other indications.
    Ayyala-Somayajula D; Dodge JL; Zhou K; Terrault NA; Yuan L
    Hepatol Commun; 2024 Jul; 8(7):. PubMed ID: 38967588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation.
    Ahn J; Liu B; Bhuket T; Wong RJ
    Dig Dis Sci; 2017 Apr; 62(4):1051-1057. PubMed ID: 28168576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
    Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA
    J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Mandatory 6-Month Waiting Period on Waitlist and Transplant Outcomes in Patients With Hepatocellular Carcinoma.
    Nagai S; Kitajima T; Yeddula S; Salgia R; Schilke R; Abouljoud MS; Moonka D
    Hepatology; 2020 Dec; 72(6):2051-2062. PubMed ID: 32157711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma.
    Shaikh A; Goli K; Rich NE; Benhammou JN; Khaderi S; Hernaez R; Agopian VG; Vierling JM; Kim D; Ahmed A; Goss JA; Rana A; Kanwal F; Cholankeril G
    Transplant Direct; 2022 May; 8(5):e1313. PubMed ID: 35434283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waitlist mortality and transplant free survival in Hispanic patients listed for liver transplant using the UNOS database.
    Goyes D; Danford CJ; Nsubuga JP; Bonder A
    Ann Hepatol; 2021; 23():100304. PubMed ID: 33444852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
    Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
    Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Median Model for End-Stage Liver Disease at Transplant Minus 3 National Policy on Waitlist Outcomes in Patients With and Without Hepatocellular Carcinoma.
    Bernards S; Hirose R; Yao FY; Jin C; Dodge JL; Huang CY; Mehta N
    Liver Transpl; 2022 Mar; 28(3):376-385. PubMed ID: 34761847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and Ethnic Disparities in Liver Transplantation for Alcohol-associated Liver Diseases in the United States.
    Cotter TG; Mitchell MC; Patel MJ; Anouti A; Lieber SR; Rich NE; Arab JP; Díaz LA; Louissaint J; Kerr T; Mufti AR; Hanish SI; Vagefi PA; Patel MS; VanWagner LB; Lee WM; O'Leary JG; Singal AG
    Transplantation; 2024 Jan; 108(1):225-234. PubMed ID: 37340542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era.
    Shaikh A; Goli K; Lee TH; Rich NE; Benhammou JN; Keeling S; Kim D; Ahmed A; Goss J; Rana A; Singal AG; Kanwal F; Cholankeril G
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2288-2297.e4. PubMed ID: 36521738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant Reduction in Posttransplant Hepatocellular Carcinoma Recurrence in the Post 6-Mo Waiting Policy Era.
    Mahmud N; Yagan L; Hoteit MA; Reddy KR; Abt PL; Abu-Gazala S
    Transplantation; 2024 May; 108(5):1172-1178. PubMed ID: 37953481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in liver transplantation before and after introduction of the MELD score.
    Moylan CA; Brady CW; Johnson JL; Smith AD; Tuttle-Newhall JE; Muir AJ
    JAMA; 2008 Nov; 300(20):2371-8. PubMed ID: 19033587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014.
    Purnell TS; Luo X; Cooper LA; Massie AB; Kucirka LM; Henderson ML; Gordon EJ; Crews DC; Boulware LE; Segev DL
    JAMA; 2018 Jan; 319(1):49-61. PubMed ID: 29297077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnicity-Specific Differences in Liver Transplant Outcomes Among Adults With Primary Sclerosing Cholangitis: 2005-2017 United Network for Organ Sharing/Organ Procurement and Transplantation Network.
    Bayable A; Ohabughiro M; Cheung R; Wong RJ
    J Clin Exp Hepatol; 2021; 11(1):30-36. PubMed ID: 33679046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.